论文部分内容阅读
医药产业链中“研发—生产—销售”是三个最为关键的环节。从国际层面看,制药公司的核心竞争力体现在“技术创新能力——产品线”及“市场控制能力——品牌”之上,而成功的制药公司都将具有专利保护的新产品研发作为企业发展的重中之重,正所谓“没有专利就没有药物”(no patent,no drug)。但在过去的30多年里,我国多数制药公司走了一条与国际制药行业不一样的道路,借助于“中药保护品种”、“地标转国标的独家品种”及“具有行政保
Pharmaceutical industry chain ”R & D - production - sales “ is the three most crucial aspects. At the international level, the core competencies of pharmaceutical companies lie in their ”technological innovation capabilities - product lines“ and ”market control capabilities - brands.“ Successful pharmaceutical companies will have new patent protection Product development as a top priority for business development, is the so-called ”no patent, no drug “ (no patent, no drug). However, in the past 30 years or so, most pharmaceutical companies in our country have taken a path different from that of the international pharmaceutical industry. With the help of ”traditional Chinese medicine protection varieties“ and ”landmark exclusive varieties of landmarks“ and ”